Logo

Decode's Shares Up 6 Percent on Bank Upgrade

Mar 12, 2007
NEW YORK (GenomeWeb News) — Shares in Decode Genetics were up 5.7 percent, or $.22, at $4.09 after the stock was upgraded by an investment bank today.
 
Piper Jaffray upgraded the stock to “outperform” from “market perform.”
 
Decode posted a 17-percent spike in fourth-quarter revenues last week, as R&D spending rose 4 percent and loss increased 10 percent. 
 
Lehman Brothers responded last week by upgrading the stock to “equal-weight” from “underweight,” and the company’s share price rose 10 percent on Thursday.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.